The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A Phase Ib/IIa, Single Center, Randomized, open, Sofosbuvir-controlled, Multiple Ascending Dose Study to Access the Tolerability,Pharmacokinetics and Pharmacodynamics of HEC110114 Tablets in HCV-infected Subjects
Epistemonikos ID: 48db39b0df30a9e7df13a89ce1e0fdad1d6a5afe
First added on: May 06, 2024